In a recent transaction, Robert Dechant, the Chief Executive Officer of IBEX Ltd (NASDAQ:IBEX), a company currently rated with "GREAT" financial health according to InvestingPro analysis, sold 1,792 common shares of the company, totaling $40,323. The shares were sold at an average price of $22.5019 per share, with the sale executed in multiple trades at prices ranging from $22.50 to $22.52. Following this transaction, Dechant holds 226,841 shares in the company. The stock has shown strong momentum with a 35% gain over the past six months, while trading at an attractive P/E ratio of 11.2. InvestingPro analysis reveals 12 additional investment tips for IBEX, available with a subscription.
In other recent news, IBEX Ltd has reported a series of significant developments. The company completed a $70 million share repurchase, buying back 3,562,341 of its common shares from The Resource Group International Limited. This move has altered IBEX's ownership structure, ending its status as a "controlled company" under Nasdaq rules.
In terms of financial performance, IBEX Ltd started the fiscal year 2025 with record Q1 revenue of $129.7 million, a 4.1% increase from the previous year. Adjusted EBITDA rose to $15.6 million, while adjusted EPS saw a 30% increase to $0.52. Consequently, the company has raised its full-year revenue guidance to between $515 million and $525 million, with adjusted EBITDA expected to reach $67 million to $69 million.
In governance matters, during its annual general meeting, shareholders approved key proposals, including setting the board of directors' size, electing directors, and appointing Deloitte & Touche LLP as the company's auditor for the upcoming fiscal year. These recent developments demonstrate IBEX Ltd's commitment to delivering value to shareholders, optimizing its capital structure, and maintaining strong financial health.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.